Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
SM 16
Cat. No.:
OB0225LY-0193
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
SM 16 is an ALK5/ALK4 kinase inhibitor with anti-tumor effects.
Synonym:
614749-78-9; SM16; 4-[4-(1,3-Benzodioxol-5-yl)-5-(6-methyl-2-pyridinyl)-1H-imidazol-2-yl]-bicyclo[2.2.2]octane-1-carboxamide; 4-(4-(Benzo[d][1,3]dioxol-5-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)bicyclo[2.2.2]octane-1-carboxamide; 4-[4-(1,3-Benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl]bicyclo[2.2.2]octane-1-carboxamide
CAS No.:
614749-78-9
Compound CID:
10387982
Formula:
C25H26N4O3
Formula Weight:
430.5
Specification
Relative Density:
1.354 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
SM 16 can be used to study drug resistance mechanisms in cancer cells or play an important role in the development of new drugs.
Library Information
Targets:
ALK family
Receptors:
ALK4; ALK5
Pathways:
Tyrosine kinase/adaptors; Angiogenesis; Stem cells; TGF-β/Smad signaling
Plate Number:
AOCL-3
Plate Location:
d7
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
6.25 mg/mL; 14.52 mM
